Announcements, grants, awards, and other updates from the HOPE Lab.
With sponsorship from Waymo LLC, The HOPE Lab, led by Dr. Makam, is leading a multidisciplinary collaboration to evaluate whether adoption of AVs reduces road traffic injuries by leveraging San Francisco's unique single-trauma-center system.
Rob Gallo was recruited as the fourth physician-scientist in the Division beginning Summer 2025 with a focus on causal inference, artificial intelligence, and learning health systems.
Oanh began as the new Chief of the UCSF Division of Hospital Medicine based at San Francsico General Hospital beginning in November, 2024.
Led by Dr. Nguyen, SVGIP is an RCT of 300 families experiencing unstable housing or homelessness to assess the potential effects of guaranteed income payments on housing stability, health, and well-being.
She was named a Chan Zuckerberg Biohub Investigator, an independent nonprofit research initiative that empowers scientists to pursue high-risk and innovative scientific research.
Anil was quoted about a recent high-profile study retraction on timing cancer immunotherapy based on his AAOx2 substack post calling for retraction given implausibilities and red flags.
Rob's first-authored study in JGIM was featured during the 2026 SHM annual meeting. His study found continuing metformin in hospitalized patients with eGFR >30 was associated with lower 90-day mortality, hypoglycemia, and new insulin prescription.
Anil was quoted about access to LTACHs given recent closures after a Medicare payment policy change that reduced reimbursment for less sick patients.
Anil was quoted in a long-form article about serious study design and disease definition limitations that have plagued observational long COVID research that used large EHR data.
The article covered the launch of the SVGIP and included quotes from Oanh about how this study is the first trial to test the effect of guaranteed income in the U.S. as a family homelessness mitigation strategy